Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0002050471-25-000001·Medicus Pharma Ltd.
Schedule 13G ownership disclosure
MEDICUS PHARMA LTD
Common Shares, no par value · CUSIP: 58471K202
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Melani Kenneth R.
Shares: 3,323,741.00 · Class: 28.1%
- VELOCITY FUND PARTNERS, LP
Shares: 2,914,330.00 · Class: 24.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002050471-25-000001
- Form type
- SCHEDULE 13G
- Filer
- Medicus Pharma Ltd.
- CIK
- CIK 1997296
- Filed
- Feb 13, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership